REQUEST A DEMO
Total
USD $0.00
Search more companies

Thienquan Joint Stock Company (Công Ty Cp Thiên Quân) (Vietnam)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Thienquan Joint Stock Company Profile Updated: January 16, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Thienquan Joint Stock Company (Công Ty Cp Thiên Quân) is based in Vietnam, with the head office in Can Tho municipality. The company operates in the Pharmaceutical Preparation Manufacturing industry. Thienquan Joint Stock Company (Công Ty Cp Thiên Quân) was incorporated on March 02, 2012. The latest financial highlights indicate a net sales revenue increase of 5.79% in 2024. During that time, Thienquan Joint Stock Company (Công Ty Cp Thiên Quân)’s total assets decreased by 0.12%. Thienquan Joint Stock Company (Công Ty Cp Thiên Quân)’s net profit margin decreased by 0.35% in 2024.

Headquarters
Lot 17F2-17F8, Street No. 5 Tra Noc 1 Industrial Park Tra Noc Ward
Can Tho municipality; Mekong River Delta;

Contact Details: Purchase the Thienquan Joint Stock Company (Công Ty Cp Thiên Quân) report to view the information.

Website: http://thienquanjsc.com/

Basic Information
Financial Auditors:
Purchase the Thienquan Joint Stock Company (Công Ty Cp Thiên Quân) report to view the information.
Incorporation Date:
March 02, 2012
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
97%
Company Performance
Financial values in the chart are available after Thienquan Joint Stock Company (Công Ty Cp Thiên Quân) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency VND. Absolute financial data is included in the purchased report.
Net sales revenue
5.79%
Total Operating Revenue
5.79%
Operating Profit
23.4%
EBITDA
27.93%
Net Profit/Loss for the Period
-68.04%
Total Assets
-0.12%
Total Equity
0.36%
Operating Profit Margin
0.56%
Net Profit Margin
-0.35%
Return on Equity (ROE)
-0.78%
Debt / Equity
-21.79%
Quick Ratio
-0.43%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?